These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26617710)

  • 1. Impairment of mesenchymal stem cells derived from oral leukoplakia.
    Zhang Z; Song J; Han Y; Mu D; Su S; Ji X; Liu H
    Int J Clin Exp Pathol; 2015; 8(9):10026-37. PubMed ID: 26617710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
    Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
    J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mucosal mesenchymal stem cell‑derived exosomes: A potential therapeutic target in oral premalignant lesions.
    Li W; Han Y; Zhao Z; Ji X; Wang X; Jin J; Wang Q; Guo X; Cheng Z; Lu M; Wang G; Wang Y; Liu H
    Int J Oncol; 2019 May; 54(5):1567-1578. PubMed ID: 30896790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion.
    Ma N; Tagawa T; Hiraku Y; Murata M; Ding X; Kawanishi S
    Nitric Oxide; 2006 Mar; 14(2):137-43. PubMed ID: 16290060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type IV collagen and C-erbB-2 expression in oral candidal leukoplakia].
    Gao Y; Liu X; Han Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Nov; 34(6):325-7. PubMed ID: 11776869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative characteristics of laryngeal-resident mesenchymal stromal cell populations isolated from distinct sites in the rat larynx.
    Lee S; Kim Y; Shin HS; Lim JY
    Stem Cell Res Ther; 2017 Sep; 8(1):200. PubMed ID: 28962587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression of Col IV, gelatinase and TIMP-1 in oral leukoplakia.
    Zhang Z; Guo W; Zhang Y; Wang X; Liu H; Xu S; Zhao Z; Chen D
    Int J Clin Exp Pathol; 2017; 10(8):8535-8543. PubMed ID: 31966707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight.
    Bruna F; Plaza A; Arango M; Espinoza I; Conget P
    Stem Cell Res Ther; 2018 May; 9(1):137. PubMed ID: 29751770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of mesenchymal stem cells in regenerative medicine.
    Kariminekoo S; Movassaghpour A; Rahimzadeh A; Talebi M; Shamsasenjan K; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):749-57. PubMed ID: 26757594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.
    Antoon R; Yeger H; Loai Y; Islam S; Farhat WA
    J Biomed Mater Res A; 2012 Jan; 100(1):72-83. PubMed ID: 21972045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
    Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
    J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell proliferation in oral candidal leukoplakia].
    Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Jan; 28(1):35-7, 64. PubMed ID: 8222947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological classification of oral leukoplakia (author's transl)].
    Burkhardt A; Seifert G
    Dtsch Med Wochenschr; 1977 Feb; 102(7):223-9. PubMed ID: 836383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins (HSP70 and HSP27) as markers of epithelial dysplasia in oral leukoplakia.
    Seoane JM; Varela-Centelles PI; Ramirez JR; Cameselle-Teijeiro J; Romero MA; Aguirre JM
    Am J Dermatopathol; 2006 Oct; 28(5):417-22. PubMed ID: 17012917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The correlation analysis between frequency of micronucleated cells of exfoliated oral mucosa cells and oral mucosa cells in different grading of oral leukoplakia lesions].
    Sun Z; Li N; Zhang Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Nov; 35(6):439-41. PubMed ID: 11780528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular risk markers for malignant transformation of oral mucosal leukoplakia ].
    Skorodumova LO; Muriaev AA; Volodina EV; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
    Vopr Onkol; 2012; 58(3):327-32. PubMed ID: 22888646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.